These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 31914026)
1. The prognostic value of long non-coding RNA H19 in various cancers: A meta-analysis based on 15 studies with 1584 patients and the Cancer Genome Atlas data. Yu H; Li S; Wu SX; Huang S; Li S; Ye L Medicine (Baltimore); 2020 Jan; 99(2):e18533. PubMed ID: 31914026 [TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis. Liu FT; Pan H; Xia GF; Qiu C; Zhu ZM Oncotarget; 2016 Dec; 7(50):83177-83186. PubMed ID: 27825121 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA H19 can predict a poor prognosis and lymph node metastasis: a meta-analysis in human cancer. Chen T; Yang P; He ZY Minerva Med; 2016 Aug; 107(4):251-8. PubMed ID: 27348443 [TBL] [Abstract][Full Text] [Related]
4. A study of the prognostic value of long non-coding RNA CASC15 in human solid tumors utilizing The Cancer Genome Atlas (TCGA) datasets and a meta-analysis. Chen W; Qian W; Nie J; Dai M Clin Exp Med; 2023 Feb; 23(1):65-78. PubMed ID: 35103883 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of long non-coding RNA five prime to XIST in various cancers. Zhou J; Chen J; Chen Z; Wu G; Zhou Z; Wu T; Wang W; Luo Y; Liu T BMC Cancer; 2022 Jan; 22(1):61. PubMed ID: 35027040 [TBL] [Abstract][Full Text] [Related]
6. High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers. Peng L; Yuan XQ; Liu ZY; Li WL; Zhang CY; Zhang YQ; Pan X; Chen J; Li YH; Li GC Oncotarget; 2017 Jan; 8(1):1655-1667. PubMed ID: 27926484 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis. Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis. Zhong P; Hua H; Chen S; Zhu Z; Xie F Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192 [TBL] [Abstract][Full Text] [Related]
9. LncRNA NORAD as a Novel Predictor of Lymph Node Metastasis and Prognosis in Solid Tumors: A Systematic Review and Meta-Analysis. Ye T; Ye Z Technol Cancer Res Treat; 2020; 19():1533033820963586. PubMed ID: 33016254 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: A meta-analysis. Meng Y; Liu YL; Li K; Fu T Medicine (Baltimore); 2019 May; 98(21):e15793. PubMed ID: 31124974 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis. Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102 [No Abstract] [Full Text] [Related]
12. Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis. Ye J; Sun H; Feng Z; Zhang Q; Xia Y; Ji Y; Zhang Q Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31227613 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CYTOR in cancer: A TCGA data review. Liang J; Wei X; Liu Z; Cao D; Tang Y; Zou Z; Zhou C; Lu Y Clin Chim Acta; 2018 Aug; 483():227-233. PubMed ID: 29750962 [TBL] [Abstract][Full Text] [Related]
14. Prognostic effect of lncRNA SNHG7 on cancer outcome: a meta and bioinformatic analysis. Zhang Y; Tian Q; Huang S; Wang Q; Wu H; Dong Q; Chen X BMC Cancer; 2022 Jan; 22(1):10. PubMed ID: 34979987 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis. Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors. Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453 [TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis. Liu X; Huang G; Zhang J; Zhang L; Liang Z PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949 [TBL] [Abstract][Full Text] [Related]
18. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers. Zhang C; Ren X; Liu Z; Tu C BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis. Zhang S; Qiu D; Xie X; Shen Y BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469 [TBL] [Abstract][Full Text] [Related]
20. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets. Shu Q; Liu X; Yang J; Mou T; Xie F Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]